About SciGenom
SciGenom is a company based in Kochi (India) founded in 2009 by Sam Santhosh. SciGenom has raised $364.03 thousand across 2 funding rounds from investors including Department of Biotechnology, Shreedharn Nair and Jlds Research AND Consultancy. The company has 12 employees as of March 31, 2024. SciGenom operates in a competitive market with competitors including Novogene Corporation, Rejuvenate Bio, Source BioScience, Strateos and Beikang Medical, among others.
- Headquarter Kochi, India
- Employees 12 as on 31 Mar, 2024
- Founders Sam Santhosh
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
$688.87 K (USD)2as on Mar 31, 2024
-
Net Profit
$65.84 K (USD)111as on Mar 31, 2024
-
EBITDA
$136.49 K (USD)127as on Mar 31, 2024
-
Total Equity Funding
$364.03 K (USD)
in 2 rounds
-
Latest Funding Round
Not available
-
Investors
Department of Biotechnology
& 2 more
-
Employee Count
12
as on Mar 31, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of SciGenom
SciGenom has successfully raised a total of $364.03K across 2 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in SciGenom
SciGenom has secured backing from 3 investors, including institutional and angel investors. Prominent investors backing the company include Department of Biotechnology, Shreedharn Nair and Jlds Research AND Consultancy.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Biotechnology research, guidelines, and funding by the Government of India.
|
Locked | Locked | Locked | |
|
-
|
Locked | Locked | Locked | |
|
SN
Shreedharn Nair |
-
|
Locked | Locked | Locked |
Investor details for SciGenom
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by SciGenom
Investment portfolio details for SciGenom
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - SciGenom
Detailed financials for SciGenom
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Scigenom Comparisons
Peer comparison for SciGenom
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of SciGenom
SciGenom operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Novogene Corporation, Rejuvenate Bio, Source BioScience, Strateos and Beikang Medical, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Genomic services and solutions with NGS expertise are provided.
|
|
| Locked | Locked | Locked |
Gene-editing platform and anti-aging therapy for dogs are developed.
|
|
| Locked | Locked | Locked |
Multiple genomic services are provided for analysis and diagnostics.
|
|
| Locked | Locked | Locked |
Provider of cloud based platform provides data driven information for biotech research
|
|
| Locked | Locked | Locked |
NGS-based diagnostic solutions for neonatal screening are developed.
|
|
| Locked | Locked | Locked |
Next-generation sequencing and genomics services are provided globally.
|
Detailed competitors of SciGenom
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Scigenom
Complete news archive for SciGenom
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about SciGenom
SciGenom was founded in 2009 and raised its 1st funding round 3 years after it was founded.
SciGenom is headquartered in Kochi, India. It is registered at Kochi, Kerala, India.
Sam Santhosh is the current CEO of SciGenom. They have also founded this company.
SciGenom is a funded company, having raised a total of $364.03K across 2 funding rounds to date.
As of Mar 31, 2024, the latest employee count at SciGenom is 12.
Annual revenue of SciGenom is $688.87K as on Mar 31, 2024.
SciGenom was founded in 2009 and is based in Kochi, India. Genome sequencing services, including next-generation and Sanger methods, are offered alongside bioinformatics tools for data analysis and laboratory information management. Additional operations encompass custom oligonucleotide synthesis, microbial identification, and cloning. Grants from DBT under SBIRI and BIPP have supported development of single-tube multigene oncodiagnostic tests compatible with NGS platforms, serving the life science and healthcare sectors.
SciGenom's top competitors include Novogene Corporation, Source BioScience and Genewiz.
SciGenom has 3 investors. Key investors include Department of Biotechnology, Shreedharn Nair, and Jlds Research AND Consultancy.
The valuation of SciGenom is $379.92K as of Mar 2012.